In breast cancer, high expression of TP63 coupled with STAT6 has been shown to be associated with longer metastasis-free survival, indicating that TP63 could be involved in inhibiting the migration of breast cancer cells (Papageorgis et al., 2015). Here, TP63 is linked to breast cancer.